期刊文献+

多学科技术联合^(125)Ⅰ治疗癌梗阻性黄疸 被引量:4

Combination of multi-disciplinary techniques with ^(125)Ⅰ seeds in treating malignant obstructive jaundice
下载PDF
导出
摘要 目的探讨多学科技术联合125Ⅰ治疗恶性梗阻性黄疸的疗效及不良反应。方法18例癌性梗阻性黄疸,A组9例,采用经食管逆行胆管引流(ERBD)术后CT引导下植入125Ⅰ粒子,B组9例,术中植入125Ⅰ后行胆肠吻合术,2个月后观察经两个方案治疗后缓解率并复查肝功能。结果A组肿瘤缓解率为44%,B组肿瘤缓解率为56%,两组肿瘤缓解率差异无统计学意义(P>0.05),肝功能恢复也无明显差异(P>0.05)。结论多学科技术联合125Ⅰ治疗癌梗阻性黄疸有较好疗效,术中与CT引导下植入对于肿瘤缓解率、肝功能恢复无明显差异,CT引导下植入患者术后恢复较快。 Objective To explore the effectiveness and safety of the combined multi-disciplinary techniques with ^125I seeds to treat the malignant obstructive jaundice. Methods 18 cases of malignant obstructive jaundice were divided into 2 groups. A group with ERBD technique followed by CT-guided interstitial ^125 I seeds implantation, B group with ^125 I seeds implantation during the operation and gallbladder-intestine anastomosis later on. After 2 months amelioration (CR,PR,SD,PD)of the obstructive jaundice was observed with inspection of liver functions. Results All cases were ameliorated with 44% patients in group A and 56% patients in group B, showing no significant statistical difference (P 〉 0.05) ; and the liver functions were also relieved in both groups with no statistical significance (P 〉 0.05). Conclusion Multi-disciplinary techniques combined with ^125 I seeds implantation is effective in the management of the malignant obstructive jaundice. No significant difference for relief and liver function were found between CT- guided and during operation interstitial ^125 I seeds implantations, but it seems more quickly relief or recovery was achieved in the latter.
出处 《介入放射学杂志》 CSCD 2008年第5期346-348,共3页 Journal of Interventional Radiology
关键词 恶性梗阻性黄疸 胰腺癌 肝功能 ^125I粒子 术中植入 Malignant obstructive jaundice Pancreatic carcinoma Liver function ^125 I seed Implantation during operation
  • 相关文献

参考文献4

二级参考文献14

  • 1谢大业,沈坤炜,夏长华.肺癌规范性手术及术中组织间放疗[J].现代诊断与治疗,1994,5(4):203-205. 被引量:12
  • 2Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys,2000,47:1261-1266.
  • 3Willins J, Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys,1997,39:347-353.
  • 4Molloy JA, Williams MB. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys,1999,26:1943-1951.
  • 5Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer,1999,85:1218-1225.
  • 6Vikram B, Mishra S.Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck,1994,16:155-157.
  • 7Kumar PP, Patil AA, Leibrock LG,et al. Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. Int J Radiat Oncol Biol Phys,1993,25:325-328.
  • 8Lee DJ, Liberman FZ, Park RI, et al. Intraoperative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology,1991,178:879-882.
  • 9Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology, 1987,164:735-740.
  • 10Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg,2003,75:237-243.

共引文献157

同被引文献10

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部